These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32708855)

  • 21. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
    Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
    Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
    Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular Vesicle-Mediated Modulation of Stem-like Phenotype in Breast Cancer Cells under Fluid Shear Stress.
    Brown SR; Radcliffe ME; Danner JT; Andújar Cruz WJ; Lackey KH; Park HA; Weinman ST; Kim Y
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
    Triantafillu UL; Park S; Klaassen NL; Raddatz AD; Kim Y
    Int J Oncol; 2017 Mar; 50(3):993-1001. PubMed ID: 28197635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers.
    Klotz R; Thomas A; Teng T; Han SM; Iriondo O; Li L; Restrepo-Vassalli S; Wang A; Izadian N; MacKay M; Moon BS; Liu KJ; Ganesan SK; Lee G; Kang DS; Walmsley CS; Pinto C; Press MF; Lu W; Lu J; Juric D; Bardia A; Hicks J; Salhia B; Attenello F; Smith AD; Yu M
    Cancer Discov; 2020 Jan; 10(1):86-103. PubMed ID: 31601552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting Breast Cancer Circulating Tumor Cells Competence via Modelling Metastasis in Zebrafish.
    Martínez-Pena I; Hurtado P; Carmona-Ule N; Abuín C; Dávila-Ibáñez AB; Sánchez L; Abal M; Chaachou A; Hernández-Losa J; Cajal SRY; López-López R; Piñeiro R
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
    Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
    Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells.
    Forsare C; Bendahl PO; Moberg E; Levin Tykjær Jørgensen C; Jansson S; Larsson AM; Aaltonen K; Rydén L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
    Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
    BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients.
    Krawczyk N; Neubacher M; Meier-Stiegen F; Neubauer H; Niederacher D; Ruckhäberle E; Mohrmann S; Hoffmann J; Kaleta T; Banys-Paluchowski M; Reinecke P; Esposito I; Janni W; Fehm T
    BMC Cancer; 2019 Nov; 19(1):1101. PubMed ID: 31718606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts.
    Shaw JA; Guttery DS; Hills A; Fernandez-Garcia D; Page K; Rosales BM; Goddard KS; Hastings RK; Luo J; Ogle O; Woodley L; Ali S; Stebbing J; Coombes RC
    Clin Cancer Res; 2017 Jan; 23(1):88-96. PubMed ID: 27334837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
    Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
    Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular profiles of single circulating tumor cells from early breast cancer patients with different lymph node statuses.
    Pang S; Xu S; Wang L; Wu H; Chu Y; Ma X; Li Y; Zou B; Wang S; Zhou G
    Thorac Cancer; 2023 Jan; 14(2):156-167. PubMed ID: 36408679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.
    Menyailo ME; Tretyakova MS; Denisov EV
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance.
    Zhou J; Zhu X; Wu S; Guo J; Zhang K; Xu C; Chen H; Jin Y; Sun Y; Zheng S; Chen Y
    Cancer Biol Med; 2020 Feb; 17(1):169-180. PubMed ID: 32296584
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.
    Hayashi N; Yamauchi H
    Breast Cancer; 2012 Apr; 19(2):110-7. PubMed ID: 21643809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between Stemness, Reactive Oxygen Species, and Epithelial-to-Mesenchymal Transition in Model Circulating Tumor Cells.
    Brown SR; Bates JC; Avera AD; Kim Y
    Cells Tissues Organs; 2022; 211(3):282-293. PubMed ID: 34077929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer.
    Papadaki MA; Kallergi G; Zafeiriou Z; Manouras L; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
    BMC Cancer; 2014 Sep; 14():651. PubMed ID: 25182808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
    Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S
    Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A conduit to metastasis: circulating tumor cell biology.
    Micalizzi DS; Maheswaran S; Haber DA
    Genes Dev; 2017 Sep; 31(18):1827-1840. PubMed ID: 29051388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.